Web13. okt 2024 · DESCRIPTION. PHESGO is a combination of pertuzumab, trastuzumab, and hyaluronidase. Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). Pertuzumab is produced by recombinant DNA technology in a … WebHER2 is found on the outside of some cancer cells and it stimulates their growth. Phesgo® belongs to a group of cancer drugs called monoclonal antibodies. Monoclonal antibodies are sometimes called targeted therapies because they work by ‘targeting’ specific proteins (receptors) on the surface of cells. Phesgo® locks onto the HER2 protein.
Trastuzumab and pertuzumab Macmillan Cancer Support
WebPhesgo ist zur Anwendung in Kombination mit Docetaxel bei erwachsenen Patienten mit HER2-positivem metastasiertem oder lokal rezidivierendem, inoperablem Brustkrebs … WebCómo se dice phesgo Inglés? Pronunciación de phesgo con 2 pronunciaciones de audio, 2 frases y más de phesgo. mat tonti
Phesgo ( pertuzumabum/trastuzumabum - European Medicines …
WebPhesgo je kontraindikovaný u pacientov so známou precitlivenosťou na pertuzumab, trastuzumab alebo na ktorúkoľvek z jeho pomocných látok (pozri časť 4.3). … WebPhesgo ® contém pertuzumabe e trastuzumabe, que são anticorpos monoclonais recombinantes humanizados direcionados contra a proteína HER2 da célula de câncer, e fazem com que ela pare de se multiplicar e se autodestrua.. Além disso, pertuzumabe e trastuzumabe agem na toxicidade celular por meio de determinados anticorpos do … Web23. dec 2024 · 罗氏(Roche)近日宣布,欧盟委员会(EC)已批准Phesgo(pertuzumab/trastuzumab/hyaluronidase)皮下注射液,该药是由Perjeta(pertuzumab,帕妥珠单抗)和Herceptin(trastuzumab,曲妥珠单抗)与透明质酸酶(hyaluronidase)构成的一种固定剂量组合(FDC),通过皮下注射(SC)给药,联 … matt onslow walcha